Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul 15;120(14):2183-90.
doi: 10.1002/cncr.28683. Epub 2014 Apr 7.

Guideline-concordant cancer care and survival among American Indian/Alaskan Native patients

Sara H Javid  1 , Thomas K Varghese, Arden M Morris, Michael P Porter, Hao He, Dedra Buchwald, David R Flum; Collaborative to Improve Native Cancer Outcomes (CINCO)
Affiliations

Guideline-concordant cancer care and survival among American Indian/Alaskan Native patients

Sara H Javid et al. Cancer. .

Abstract

Background: American Indians/Alaskan Natives (AI/ANs) have the worst 5-year cancer survival of all racial/ethnic groups in the United States. Causes for this disparity are unknown. The authors of this report examined the receipt of cancer treatment among AI/AN patients compared with white patients.

Methods: This was a retrospective cohort study of 338,204 patients who were diagnosed at age ≥65 years with breast, colon, lung, or prostate cancer between 1996 and 2005 in the Surveillance, Epidemiology, and End Results-Medicare database. Nationally accepted guidelines for surgical and adjuvant therapy and surveillance were selected as metrics of optimal, guideline-concordant care. Treatment analyses compared AI/ANs with matched whites.

Results: Across cancer types, AI/ANs were less likely to receive optimal cancer treatment and were less likely to undergo surgery (P ≤ .025 for all cancers). Adjuvant therapy rates were significantly lower for AI/AN patients with breast cancer (P < .001) and colon cancer (P = .001). Rates of post-treatment surveillance also were lower among AI/ANs and were statistically significantly lower for AI/AN patients with breast cancer (P = .002) and prostate cancer (P < .001). Nonreceipt of optimal cancer treatment was associated with significantly worse survival across cancer types. Disease-specific survival for those who did not undergo surgery was significantly lower for patients with breast cancer (hazard ratio [HR], 0.62), colon cancer (HR, 0.74), prostate cancer (HR, 0.52), and lung cancer (HR, 0.36). Survival rates also were significantly lower for those patients who did not receive adjuvant therapy for breast cancer (HR, 0.56), colon cancer (HR, 0.59), or prostate cancer (HR, 0.81; all 95% confidence intervals were <1.0).

Conclusions: Fewer AI/AN patients than white patients received guideline-concordant cancer treatment across the 4 most common cancers. Efforts to explain these differences are critical to improving cancer care and survival for AI/AN patients.

Keywords: Alaskan Native; American Indian; cancer; guidelines; treatment.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST DISCLOSURES

Dr. Flum reports a paid salary from the Patient Centered Outcomes Research Institute (PCORI) and travel expenses for meetings of the PCORI Methodology Committee; he is an owner of Surgical Consulting, LLC,; he is a paid consultant to Pacira Pharmaceuticals; he is a co-owner of Benchmarket, LLC; and, at the American College of Surgeons, he is former Chair for the Surgical Research Committee and current Chair for the Bi-Annual Outcomes Research Course, for which he receives travel expenses. He has received research funding from Nestle Health Sciences for the Strong for Surgery Initiative. He also reports the receipt of travel expenses for national and international meetings and symposiums from Covidien, the Australia New Zealand Hepato-Biliary Association, and Kenes International; and he reports honorarium and travel expenses for meetings and presentations from the American Academy of Orthopedic Surgeons and Nestle Health Sciences.

Figures

Figure 1
Figure 1
The likelihood of receiving optimal care among American Indians/Alaskan Natives (AI/ANs) compared with whites is illustrated. Multivariate logistic regression modeling is shown for Metric 1 (surgery/primary care) and Metric 2 (adjuvant therapy) for each cancer. Covariates included race; age at diagnosis; Surveillance, Epidemiology, and End Results registry site; year of diagnosis; cancer stage; and Charlson comorbidity index. LCL indicates lower control limit; UCL, upper control limit.
Figure 2
Figure 2
The association between receipt of optimal care and survival is illustrated. Cox proportional hazards regression modeling was used to estimate the adjusted hazard ratios associated with receipt of Metric 1 (surgery/primary care) and Metric 2 (adjuvant therapy). The models were adjusted for race; age at diagnosis; Surveillance, Epidemiology, and End Results registry site; year of diagnosis; cancer stage; and Charlson Comorbidity Index. LCL indicates lower control limit; UCL, upper control limit.
See this image and copyright information in PMC

References

    1. US Department of Health and Human Services (DHHS) DHHS Publication No. 271-848-40085. 3. Washington, DC: US Government Printing Office; 1991. Health Status of Minorities and Low-Income Groups. [reprinted as: National Cancer Institute. NIH Publication No. 94-3603. Bethesda, MD; National Institutes of Health; 1994]
    1. Espey DK, Wu XC, Swan J, et al. Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives. Cancer. 2007;110:2119–2152. - PubMed
    1. Greenberg CC, Lipsitz SR, Neville B, et al. Receipt of appropriate surgical care for Medicare beneficiaries with cancer. Arch Surg. 2011;146:1128–1134. - PMC - PubMed
    1. Cobb N, Paisano RE. Patterns of cancer mortality among Native Americans. Cancer. 1998;83:2377–2383. - PubMed
    1. Cobb N, Wingo PA, Edwards BK. Introduction to the supplement on cancer in the American Indian and Alaska Native populations in the United States. Cancer. 2008;113(5 suppl):1113–1116. - PubMed

Publication types

MeSH terms